Abstract
By using the wet precipitation method, Biphasic calcium phosphate granules were synthesized with Ca/P ratio1.52 and controlled porosity, pore size distribution, and granule size. Microporosity was then obtained by adjusting sintering temperature while macroporosity was prepared by adding 1:3 wt% ratio of two normally used porogens (naphthalene and sugar) and 2 newly introduced porogens (sago and lentil). Samples from each ratio were pressed into pellets and were fired at 500?C for 2 hours with 0.5?C/minute heating rate (for removal of porogens) and further sintered at 850?C for 2 hours with 5?C/minute before cooling down to room temperature. The granules were prepared by crushing and sieving BCP sintered pellets to get granules of sizes ranging from 250-500?m. X-rays diffraction (XRD), field emission scanning electron microscope (FESEM), particle size and porosity analyses were employed in order to characterize the granules. A round to oval shape pores with 200-400 ?m size were obtained and identical to the prepared porogens? particle size. This approach gives the desirable properties near to normal bone leading to a perfect osteogenesis for the purpose tissue engineering.
Highlights
Biphasic calcium phosphate (BCP) a biomaterial consists of a mixture of hydroxy apatite (HA) and ß-tricalcium phosphate (ß-TCP) which belong to calcium phosphate ceramics (CaPCs) [1,2,3]
For ß-TCP it shows three high intensity peaks located at 27.9°, 31.2° and 34.4° while the highest peaks for HA are at 31.8° and 32.9°
A new approach was developed to assure the desirable properties of BCP in terms of biocompatibility and scaffolding from different porogens to meet the osteogenesis requirements of normal bone for tissue engineering purpose
Summary
Biphasic calcium phosphate (BCP) a biomaterial consists of a mixture of hydroxy apatite (HA) and ß-tricalcium phosphate (ß-TCP) which belong to calcium phosphate ceramics (CaPCs) [1,2,3]. It is biocompatible, biocontactive material and possesses reasonable biodegradable properties, depending on HA: ß-TCP ratio. The desired scaffolding by BCP is facilitated by osteogenic and/or growth factor to optimize tissue in which the process requires a biocompatible carrier to transfer the stem cells [5].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.